Progress of drug therapy for psychosis in Parkinson's disease
10.3760/cma.j.issn.1008-1372.2018.07.053
- VernacularTitle:帕金森病精神障碍的药物治疗进展
- Author:
Yang LIU
1
;
Youdong WEI
Author Information
1. 重庆市神经病学重点实验室
- Keywords:
Parkinson disease/CO/DT;
Mental disorders/ET/DT;
Review
- From:
Journal of Chinese Physician
2018;20(7):1113-1116
- CountryChina
- Language:Chinese
-
Abstract:
Parkinson's disease (PD) is a common degenerative neurological disease in middle-aged and elderly people,which is characterized by typical motor symptoms.The accompanying non-motor symptoms are also getting increasingly attention.Among them,psychosis associated with Parkinson's disease accounted for 30％-80％ of patients with Parkinson~ disease,mainly in PD patients treated for 10 years or more,and the severity of mental symptoms have a greater impact on the quality of life of patients.This article provides a brief review of the current state of drug treatment for psychosis associated with Parkinson's disease (PDPs).
